Detalhe da pesquisa
1.
Inhibition of IL1ß by Canakinumab May Be Effective against Diverse Molecular Subtypes of Lung Cancer: An Exploratory Analysis of the CANTOS Trial.
Cancer Res
; 80(24): 5597-5605, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33023946